Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

2.

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J.

BMJ. 1993 Mar 13;306(6879):683-7.

3.

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002791. Review.

PMID:
17636706
4.

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2000;(4):CD002791. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD002791.

PMID:
11034764
5.

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D.

Int Clin Psychopharmacol. 1994 Spring;9(1):47-53. Erratum in: Int Clin Psychopharmacol 1994 Winter;9(4):following 296.

PMID:
8195583
6.

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.

MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I.

BMJ. 2003 May 10;326(7397):1014. Review.

7.
8.

Are SSRIs a cost-effective alternative to tricyclics?

Hotopf M, Lewis G, Normand C.

Br J Psychiatry. 1996 Apr;168(4):404-9.

PMID:
8730935
9.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C.

Health Technol Assess. 2005 May;9(16):1-134, iii.

10.

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Montgomery SA, Kasper S.

Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:33-40.

PMID:
7622822
11.
12.

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.

PMID:
19165525
14.
15.

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.

Williams JW Jr, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J.

Ann Intern Med. 2000 May 2;132(9):743-56. Review.

PMID:
10787370
16.

[Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].

Cvjetković-Bosnjak M, Knezević A, Soldatović-Stajić B.

Med Pregl. 1999 Mar-May;52(3-5):108-11. Croatian.

PMID:
10518394
18.

Antidepressants and the risk of falls among nursing home residents.

Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA.

N Engl J Med. 1998 Sep 24;339(13):875-82.

20.

Supplemental Content

Support Center